Ingevity Corp (NGVT) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-05-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	8-K	10-K	10-K
Revenues:
Performance Chemicals	1,119.8	874.7	706.1	802.3	733.2		623.1
Performance Materials	548.5	516.8	510.0	490.6	400.4		349.3
Europe, Middle East, and Africa	242.2	219.6	174.9	193.6	169.9		149.2
Total revenues	1,668.3	1,391.5	1,216.1	1,292.9	1,133.6	1,133.6	972.4	908.3
Revenue growth [+]	19.9%	14.4%	-5.9%	14.1%	16.6%		7.1%	-5.2%
Performance Chemicals	28.0%	23.9%	-12.0%	9.4%	17.7%
Performance Materials	6.1%	1.3%	4.0%	22.5%	14.6%
Europe, Middle East, and Africa	10.3%	25.6%	-9.7%	13.9%	13.9%
Cost of goods sold	1,098.2	878.7	750.6	810.9	716.8	716.8	643.4	633.9
Gross profit	570.1	512.8	465.5	482.0	416.8	416.8	329.0	274.4
Gross margin	34.2%	36.9%	38.3%	37.3%	36.8%	36.8%	33.8%	30.2%
Selling, general and administrative [+]	198.8	179.3	149.4	163.1	132.4	132.4	106.4	113.9
Sales and marketing								96.4
General and administrative								17.5
Other selling, general and administrative								96.4
Research and development	30.3	26.3	22.6	19.7	21.5	21.5	19.8	17.6
Other operating expenses	15.0	9.8	22.4	26.1	-2.2	0.5	4.4	41.9
EBITDA [+]	434.8	407.3	371.3	358.1	322.1	319.4	238.8	139.8
EBITDA growth	6.8%	9.7%	3.7%	11.2%	34.9%		70.8%	-27.0%
EBITDA margin	26.1%	29.3%	30.5%	27.7%	28.4%	28.2%	24.6%	15.4%
Depreciation	75.2	76.7	67.6	56.3	44.7	57.0	38.0	36.1
EBITA	359.6	330.6	303.7	301.8	277.4	262.4	200.8	103.7
EBITA margin	21.6%	23.8%	25.0%	23.3%	24.5%	23.1%	20.6%	11.4%
Amortization of intangibles	33.6	33.2	32.6	28.7	12.3		2.4	2.7
EBIT [+]	326.0	297.4	271.1	273.1	265.1	262.4	198.4	101.0
EBIT growth	9.6%	9.7%	-0.7%	3.0%	33.6%		96.4%	-35.6%
EBIT margin	19.5%	21.4%	22.3%	21.1%	23.4%	23.1%	20.4%	11.1%
Non-recurring items	3.8	7.0	-2.1	2.6	12.5	10.8	8.0	-0.7
Interest expense, net [+]	54.3	47.7	42.2	46.9	29.8	29.8	15.8	17.9
Interest expense	61.8	51.7	47.1	54.6	33.2	29.8	18.1	19.3
Interest income	7.5	4.0	4.9	7.7	3.4		2.3	1.4
Other income (expense), net [+]	1.7	-79.9	4.1	4.3	-1.0		0.2	3.2
Acquisition-related costs	5.0	0.6	1.8	26.9
Other	1.7	-79.9	4.1	4.3	-1.0		0.2	3.2
Pre-tax income	269.6	162.8	235.1	227.9	221.8	221.8	174.8	87.0
Income taxes	58.0	44.7	53.7	44.2	40.0	40.0	29.6	42.6
Tax rate	21.5%	27.5%	22.8%	19.4%	18.0%	18.0%	16.9%	49.0%
Minority interest					12.7		18.7	9.2
Net income	211.6	118.1	181.4	183.7	169.1	181.8	126.5	35.2
Net margin	12.7%	8.5%	14.9%	14.2%	14.9%	16.0%	13.0%	3.9%

Basic EPS [+]	$5.54	$2.97	$4.39	$4.39	$4.02	$4.33	$3.00	$0.84
Growth	86.9%	-32.4%	-0.1%	9.2%	34.0%		259.2%	-55.8%
Diluted EPS [+]	$5.50	$2.95	$4.37	$4.35	$3.97	$4.27	$2.97	$0.83
Growth	86.6%	-32.5%	0.3%	9.7%	33.4%		257.2%	-56.0%

Dividends per share [+]								$10.65
Growth							-100.0%

Shares outstanding (basic) [+]	38.2	39.8	41.3	41.8	42.0	42.0	42.1	42.1
Growth	-4.1%	-3.7%	-1.1%	-0.6%	-0.2%		0.1%	0.0%
Shares outstanding (diluted) [+]	38.5	40.1	41.5	42.2	42.6	42.6	42.5	42.3
Growth	-4.0%	-3.6%	-1.5%	-0.9%	0.2%		0.6%	0.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.